metformin has been researched along with Prostatitis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T | 1 |
| Fujita, K | 1 |
| Matsushita, M | 1 |
| Hayashi, Y | 1 |
| Uemura, M | 1 |
| Nonomura, N | 1 |
1 other study available for metformin and Prostatitis
| Article | Year |
|---|---|
Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten-deficient model mice.
Topics: Animals; Diet, High-Fat; Disease Progression; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Trans | 2019 |